Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Pediatric Polytrauma
NCT06097611Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial in traumatic hemorrhage comparing Tranexamic Acid with Standard of Care (2 arms). Primary endpoint: Mortality Rate at 1 year. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
traumatic hemorrhage
Beyond the preview
Go deeper on NCT06097611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06097611.